S. no.
Ocular condition
Herbs reported to have beneficial effect
1
Dry eye
Natural polymer (gum) from tamarind seed, curcumin
2.
Glaucoma
Foeniculum vulgare, Lycium barbarum, Gingko biloba, Coleus forskohlii, Cannabis sativa, lutein, zeaxanthin, green tea, resveratrol, curcumin, safflower
3.
Cataract
Cineraria maritime, Momordica charantia, Eugenia jambolana, Tinospora cordifolia, T. foenum-graecum, Ocimum sanctum, P. marsupium, Murraya koenigii, Brassica juncea, Mucuna pruriens, Coleus forskohlii, Rosmarinus officinalis, Allium sativum, Ocimum sanctum, Gymnema sylvestre, Buddlejae flos, cinnamon, lutein, nobiletin, Withania somnifera, Aegle marmelos, Duchesnea chrysantha
4.
Anti-angiogenic
Gingko biloba, Vaccinium myrtillus, Stephania tetrandra, Magnolia officinalis, Dendrobium chrysotoxum, Boswellia serrata
5.
Uveitis
Curcumin, Scutellariae radix, Tripterygium wilfordii, Vaccinium myrtillus, Berberis aristata, Lonicera caerulea, fucoxanthin, lutein, Lycium
References
Agarwal R, Gupta SK, Agrawal SS, Srivastava S, Saxena R. Oculohypotensive effects of foeniculum vulgare in experimental models of glaucoma. Indian J Physiol Pharmacol. 2008;52(1):77–83.PubMed
Alekseev IB, Kochergin SA, Vorob’eva IV, Mikhaleva LG. On some pathogenic features of diabetic retinopathy in type II diabetes mellitus and the role of antioxidants and Ginkgo biloba. Vestn Oftalmol. 2013;129(3):89–93.PubMed
al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian Exp J Biol. 1999;37(2):124–30.
Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–94.PubMed
Anitha TS, Annadurai T, Thomas PA, Geraldine P. Prevention of selenite-induced cataractogenesis by an ethanolic extract of Cineraria maritima: an experimental evaluation of the traditional eye medication. Biol Trace Elem Res. 2011;143(1):425–36.PubMed
Anitha TS, Muralidharan AR, Annadurai T, Christdas Jesudasan AN, Thomas PA, Geraldine P. Putative free radical-scavenging activity of an extract of Cineraria maritima in preventing selenite-induced cataractogenesis in Wistar rat pups. Mol Vis. 2013;19:2551–60.PubMedPubMedCentral
Barabino S, Rolando M, Nardi M, Bonini S, Aragona P, Traverso CE. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye. Eur J Ophthalmol. 2014;24(2):173–8.PubMed
Bartlett H, Eperjesi F. An ideal ocular nutritional supplement? Ophthalmic Physiol Opt. 2004;24(4):339–49.PubMed
Bhardwaj A, Tanwar M. Effect of rasanjana madhu ashchyotana in netra abhishyanda (mucopurulent conjunctivitis). Ayu. 2011;32(3):365–9.PubMedPubMedCentral
Bhuyan KC, Bhuyan DK. Molecular mechanism of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res. 1984;3(1):67–81.PubMed
Biswas NR, Gupta SK, Das GK, Kumar N, Mongre PK, Haldar D, Beri S. Evaluation of Ophthacare eye drops – a herbal formulation in the management of various ophthalmic disorders. Phytother Res. 2001;15(7):618–20.PubMed
Brubaker RF, Carlson KH, Kullerstrand LJ, McLaren JW. Topical forskolin (colforsin) and aqueous flow in humans. Arch Ophthalmol. 1987;105(5):637–41.PubMed
Burgalassi S, Panichi L, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999;31(3):229–35.PubMed
Caprioli J, Sears M, Bausher L, et al. Forskolin lowers intraocular pressure by reducing aqueous inflow. Invest Ophthalmol Vis Sci. 1984;25(3):268–77.PubMed
Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol. 2008;28(5):643–52.PubMed
Chen M, Hu DN, Pan Z, Lu CW, Xue CY, Aass I. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways. Exp Eye Res. 2010;90(3):437–43.PubMed
Chien FY, Wang RF, Mittag TW, Podos SM. Effect of WIN 55212–2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys. Arch Ophthalmol. 2003;121(1):87–90.PubMed
Das GK, Pandey RM, Biswas NR. Comparative double masked randomised placebo controlled clinical trial of a herbal eye drop preparation in trachoma and conjunctivitis. J Indian Med Assoc. 1995;93(10): 383–4.
Deng Y, Wang M, Duan J. The modality of huoxue-huayu in treatment of retinal vein occlusion. Yan Ke Xue Bao. 1995;11(1):57–60.PubMed
Dhiman KS, Sharma G, Singh S. A clinical study to assess the efficacy of Triyushnadi Anjana in Kaphaja Abhishyanda with special reference to vernal keratoconjunctivitis. Ayu. 2010;31(4):466–72.PubMedPubMedCentral
Dhiman KS, Ahuja DK, Sharma SK. Clinical efficacy of Ayurvedic management in computer vision syndrome: a pilot study. Ayu. 2012;33(3):391–5.PubMedPubMedCentral
Doly M, Droy-Lefaix MT, Bonhomme B, Braquet P. Effect of Ginkgo biloba extract on the electrophysiology of the isolated retina from a diabetic rat. Presse Med. 1986;15(31):1480–3.PubMed
Fischer KM, Ward DA, Hendrix DV. Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res. 2013;74(2):275–80.PubMed
Fønnebø V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launsø L, Koithan M, Falkenberg T, Boon H, Aickin M. Researching complementary and alternative treatments – the gatekeepers are not at home. BMC Med Res Methodol. 2007;7:7.PubMedPubMedCentral
Fraunfelder FW. Ocular side effects from herbal medicines and nutritional supplements. Am J Ophthalmol. 2004;138(4):639–47.PubMed
Fraunfelder FW. Ocular side effects associated with dietary supplements and herbal medicines. Drugs Today (Barc). 2005;41(8):537–45.
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364–7.PubMed
Gopinathan G, Dhiman KS, Manjusha R. A clinical study to evaluate the efficacy of Trataka Yoga Kriya and eye exercises (non-pharmocological methods) in the management of Timira (Ammetropia and Presbyopia). Ayu. 2012;33(4):543–6.PubMedPubMedCentral
Gupta SK, Srivastava S, Trivedi D, Joshi S, Halder N. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification. Curr Eye Res. 2005;30(7):583–91.PubMed
Gupta SK, Niranjan DG, Agrawal SS, Srivastava S, Saxena R. Recent advances in pharmacotherapy of glaucoma. Indian J Pharmacol. 2008; 40(5):197–208.
Gupta DP, Rajagopala M, Dhiman KS. A clinical study on Akshitarpana and combination of Akshitarpana with Nasya therapy in Timira with special reference to myopia. Ayu. 2010;31(4):473–7.PubMedPubMedCentral
Gupta SK, Kalaiselvan V, Srivastava S, Saxena R, Agrawal SS. Trigonella foenum-graecum (Fenugreek) protects against selenite-induced oxidative stress in experimental cataractogenesis. Biol Trace Elem Res. 2010;136(3):258–68.PubMed
Halder N, Joshi S, Gupta SK. Lens aldose reductase inhibiting potential of some indigenous plants. J Ethnopharmacol. 2003;86(1):113–6.PubMed
< div class='tao-gold-member'>
Only gold members can continue reading. Log In or Register a > to continue